Literature DB >> 21334934

Distribution of signs and symptoms of complex regional pain syndrome type I in patients meeting the diagnostic criteria of the International Association for the Study of Pain.

Remco D H de Boer1, Johan Marinus, Jacobus J van Hilten, Frank J Huygen, Frank van Eijs, Maarten van Kleef, Martin C R Bauer, Miriam van Gestel, Wouter W A Zuurmond, Roberto S G M Perez.   

Abstract

The aim of the present study was to describe the occurrence of signs and symptoms in CRPS I patients meeting the IASP (Orlando) criteria, assess the occurrence of signs and symptoms in relation to disease duration and compare these to historical data based on a different diagnostic criteria set. Six hundred and ninety-two ambulatory patients meeting the IASP criteria for CRPS I referred to the outpatient clinics of five participating centers were included in this cross-sectional study. Characteristics were recorded in a standardized fashion and categorized according to the factor structure proposed by Bruehl/Harden. Subgroups were classified according to the duration of complaints and compared to historical data as described by Veldman et al. The Chi-square test corrected for multiple comparisons was used for statistical analysis. The prevalence of sensory signs was higher in patients with longer disease duration, especially for the allodynia's and hyperalgesia (all p<0.001). Signs in vasomotor (color difference; p=0.0007) and sudomotor (edema; p<0.0001) subgroups were less frequently present in patients with longer disease duration (i.e. >6 months). Prevalences of signs in the motor subgroup were all higher (p<0.0001) in patients with longer disease duration, except for limited range of motion. Occurrence of signs was significantly lower (<0.001) than those reported by Veldman et al., except for hyperesthesia and dystonia. Occurrence rates may vary at different time points after onset of CRPS, which may be of influence for diagnosing patients with novel derived diagnostic criteria. We argue for a mechanism based description of CRPS I based on one set of uniform generally accepted diagnostic criteria in future studies.
Copyright © 2011 European Federation of International Association for the Study of Pain Chapters. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21334934     DOI: 10.1016/j.ejpain.2011.01.012

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  8 in total

Review 1.  Complex regional pain syndrome.

Authors:  Greta Palmer
Journal:  Aust Prescr       Date:  2015-06-01

2.  Responsiveness to botulinum toxin type A in muscles of complex regional pain patients with tonic dystonia.

Authors:  Johanna C M Schilder; J Gert van Dijk; Dirk Dressler; Johannes H T M Koelman; Johan Marinus; Jacobus J van Hilten
Journal:  J Neural Transm (Vienna)       Date:  2014-02-15       Impact factor: 3.575

3.  Implications of the putamen in pain and motor deficits in complex regional pain syndrome.

Authors:  Monica Azqueta-Gavaldon; Andrew M Youssef; Claudia Storz; Jordan Lemme; Heike Schulte-Göcking; Lino Becerra; Shahnaz C Azad; Anselm Reiners; Birgit Ertl-Wagner; David Borsook; Jaymin Upadhyay; Eduard Kraft
Journal:  Pain       Date:  2020-03       Impact factor: 7.926

4.  Predictive value of sympathetic skin response in diagnosing complex regional pain syndrome: a case-control study.

Authors:  Hyun Jung Kim; Hea Eun Yang; Dae Hyun Kim; Yoon Ghil Park
Journal:  Ann Rehabil Med       Date:  2015-02-28

5.  Pramipexole-induced limb dystonia and its associated complex regional pain syndrome in idiopathic Parkinson's disease: A case report.

Authors:  Donghwi Park
Journal:  Medicine (Baltimore)       Date:  2017-07       Impact factor: 1.889

Review 6.  Complex regional pain syndrome what is the outcome? - a systematic review of the course and impact of CRPS at 12 months from symptom onset and beyond.

Authors:  Selina Johnson; Fiona Cowell; Sharon Gillespie; Andreas Goebel
Journal:  Eur J Pain       Date:  2022-05-04       Impact factor: 3.651

Review 7.  A lateralized model of the pain-depression dyad.

Authors:  Anne Margarette S Maallo; Eric A Moulton; Christine B Sieberg; Donald B Giddon; David Borsook; Scott A Holmes
Journal:  Neurosci Biobehav Rev       Date:  2021-06-06       Impact factor: 9.052

8.  Effect of intravenous low-dose S-ketamine on pain in patients with Complex Regional Pain Syndrome: A retrospective cohort study.

Authors:  Thomas J P Mangnus; Maaike Dirckx; Krishna D Bharwani; Cecile C de Vos; Sander P G Frankema; Dirk L Stronks; Frank J P M Huygen
Journal:  Pain Pract       Date:  2021-07-24       Impact factor: 3.079

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.